Cynata Therapeutics Limited Level 3, 100 Cubitt Street, Cremorne VIC 3121 8 October 2026 Target Market Determination Made by: Cynata Therapeutics Limited ACN 104 037 372 (Issuer or Cynata) Product: Options to acquire fully paid ordinary shares (Shares) in the Issuer (Options) to be issued under...
Target Market Determination
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Prospectus
- Proposed issue of securities - CYP
- Entitlement Offer & Unmarketable Parcel Sale Facility
- Termination of At-the-Market Subscription Deed
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
Later from Cynata Therapeutics
- Replacement Prospectus
- Replacement Target Market Determination
- Letter to Eligible Shareholders-Entitlement Offer
- Letter to Ineligible Shareholders-Entitlement Offer
- Notification of buy-back - CYP
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics